Health Security Digest

Subscribe to news & information

* indicates required
View our privacy policy before signing up.
  • Reuters

    China's small farmers pose huge challenge in swine fever battle

    12 September 2018

    12 SEP - Even after 14 outbreaks of African swine fever across China in just over a month, pig farmer Wang Wu does not believe the threat to his livelihood is real. “I heard about the African swine fever thing. But then people said it was just rumor. It was fake news,” said Wang, who raises about 60 pigs in a village near Harbin, capital of China’s northeastern Heilongjiang province.

  • Global Fund

    Global Fund Results Report

    12 September 2018

    12 SEP - The Global Fund to Fight AIDS, Tuberculosis and Malaria released a report today demonstrating that 27 million lives have been saved by the Global Fund partnership. The report shows tremendous progress that has been achieved by efforts to end the epidemics, while highlighting new threats.

  • Interpreter

    PNG: new friend versus old, APEC and polio

    11 September 2018

    11 SEP - But as these two countries play out their aid-funded geostrategic dance, and PNG Prime Minister Peter O’Neill happily signs on the competing dance cards, his country becomes more beholden to unaffordable debt. This, while basic health and education services in PNG slide perilously backwards. What could be more telling of the breakdown in services than the re-emergence of polio just three months ago in the country that the World Health Organisation (WHO) had declared polio free in 2000.

  • Telegraph logo

    Pharmaceutical pollution linked to rise in superbugs

    11 September 2018

    11 SEP - Politicians have been criticised for their failure to stop manufacturers of antibiotics polluting the environment: a practice which has been linked to the global rise in superbugs.

  • CIDRAP

    Study: Flu vaccine protection starts to wane within weeks

    11 September 2018

    11 SEP - Though the US Centers for Disease Control and Prevention recommends administration of the flu vaccine by the end of October, a new study published in Clinical Infectious Diseases suggests that vaccine effectiveness may begin dropping within weeks of administration, adding more evidence of waning protection over the course of a single flu season.

  • The guardian

    Polio outbreak in Papua New Guinea reaches capital Port Moresby

    11 September 2018

    11 SEP - First case confirmed in the capital which is preparing to host high-level Apec summit, prompting an emergency vaccination campaign.

  • A practical guide for developing and conducting simulation exercise

    10 September 2018

    10 SEP - The aim of this document is to support countries in developing and conducting simulation exercises to test and validate their national pandemic influenza preparedness plans. 

  • Emerging Infectious Diseases (Journal)

    Molecular Evolution, Diversity, and Adaptation of Influenza A(H7N9) Viruses in China

    10 September 2018

    AHEAD OF PRINT (OCT 2018) - The substantial increase in prevalence and emergence of antigenically divergent or highly pathogenic influenza A(H7N9) viruses during 2016–17 raises concerns about the epizootic potential of these viruses. We investigated the evolution and adaptation of H7N9 viruses by analyzing available data and newly generated virus sequences isolated in Guangdong Province, China, during 2015–2017. Our results indicate that highly pathogenic strains likely emerged from viruses circulating in eastern Guangdong Province during March 2016 and are associated with a high rate of adaptive molecular evolution.

  • Wellcome Trust

    Antimicrobial Resistance Surveillance: Sharing industry data

    10 September 2018

    10 SEP VIA CIDRAP - A set of recommendations from a Wellcome Trust pilot project to make human antimicrobial resistance (AMR) data generated and collected by the pharmaceutical industry publicly accessible.

  • National Institute of Allergy and Infectious Diseases

    Early-Stage Clinical Trial of Antimalarial Drug Begins

    10 September 2018

    10 SEP VIA CIDRAP - Enrollment has begun in a Phase 1 clinical trial to test the safety of a new investigational drug designed to treat malaria, as well as its effect on the human body. The first-in-human study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is being conducted at the Duke University School of Medicine in Durham, North Carolina.

Pages

Subscribe to  Health Security Digest